Emerging Biosensors for Oral Cancer Detection and Diagnosis—A Review Unravelling Their Role in Past and Present Advancements in the Field of Early Diagnosis
Abstract:Oral cancer is a serious concern to people all over the world because of its high mortality rate and metastatic spread to other areas of the body. Despite recent advancements in biomedical research, OC detection at an early stage remains a challenge and is complex and inaccurate with conventional diagnostics procedures. It is critical to study innovative approaches that can enable a faster, easier, non-invasive, and more precise diagnosis of OC in order to increase the survival rate of patients. In this paper,… Show more
“…As a biofluid secreted by the parotid gland, saliva consists of several significant components, including drug metabolites, enzymes, microbial flora, and hormones . Saliva, due to its noninvasive collection, has found extensive application in electrochemical sensing for the detection of diverse biomarkers, including proteins, viruses, small molecules, and other analytes. , However, the development of wearable saliva-based biosensors has been limited due to certain challenges, including the presence of abundant salivary proteins, which can lead to biofouling and the relatively low concentration of analytes in saliva. , Recently, advancement in HWEBs has been more focused on addressing these issues.…”
Section: Hwebs For Detection Of Biofluidsmentioning
“…As a biofluid secreted by the parotid gland, saliva consists of several significant components, including drug metabolites, enzymes, microbial flora, and hormones . Saliva, due to its noninvasive collection, has found extensive application in electrochemical sensing for the detection of diverse biomarkers, including proteins, viruses, small molecules, and other analytes. , However, the development of wearable saliva-based biosensors has been limited due to certain challenges, including the presence of abundant salivary proteins, which can lead to biofouling and the relatively low concentration of analytes in saliva. , Recently, advancement in HWEBs has been more focused on addressing these issues.…”
Section: Hwebs For Detection Of Biofluidsmentioning
“…According to their signal detection, sensors can be divided into physical, chemical, thermal and biological types [29]. The pioneers of biological sensors (or biosensors) were Clark and Lyons, who, in 1962, developed the first enzyme-based glucose sensor later upgraded by Updike and Hicks [22,30]. They paved the way for devices that transform the concentration of specific and diverse biomarkers, such as proteins, DNA, RNA, antibodies or microorganisms, into an analytical signal with the help of a transducer [22,31,32], as shown in Figure 1.…”
Section: Nanobiosensors-sensing Mechanism and Attributesmentioning
confidence: 99%
“…The pioneers of biological sensors (or biosensors) were Clark and Lyons, who, in 1962, developed the first enzyme-based glucose sensor later upgraded by Updike and Hicks [22,30]. They paved the way for devices that transform the concentration of specific and diverse biomarkers, such as proteins, DNA, RNA, antibodies or microorganisms, into an analytical signal with the help of a transducer [22,31,32], as shown in Figure 1. The latter one converts the recognition signal events into a quantifiable format of electrical signals.…”
Section: Nanobiosensors-sensing Mechanism and Attributesmentioning
confidence: 99%
“…In the quest of surmounting these impediments, the preclinical sector turned to nanotechnology, a field with significant breakthroughs in the past decade, allowing the integration of diverse diagnostic modalities into a unified platform. There is evidence that sensitivity could increase 20 times more when compared to ELISA [22,23]. On one hand, in conjunction with a variety of analytical methods, it has propelled the creation of multifunctional nanocarriers-based biological sensors, which will be our focus in this paper and on the other hand there are chemical sensors, or chemosensors for short and together they have the collective goal of optimizing their performance for low-cost, portable, on-site clinical setting diagnosis [24].…”
Gastric cancer (GC) remains a significant global health challenge, with late-stage diagnosis impacting treatment options and decreased survival rates. To address this, there has been a growing interest in the development of innovative screening and diagnostic methods. Over the past 20 years, nanobiosensors have undergone multiple iterations and unveiled remarkable features that pledge to reshape patient care. Despite the excitement over the plethora of ground-breaking advancements for cancer detection, use-ready samples and streamlined healthcare information monitoring and usage, this technology is still awaiting entry into clinical trials, urging a closer gaze within the medical community. Oligonucleotide-based biosensors, leveraging DNA or RNA’s long-term storage of information, offer great specificity and sensitivity, as described throughout this paper. Consequently, this renders them as an ideal choice for revolutionizing GC diagnosis and facilitating early intervention. The aim of this review is to provide an overview of this cutting-edge, invaluable technology and its limitations across various aspects.
“…At present, a comprehensive oral examination, typically performed by a dentist or other skilled health care practitioner, is the only reliable method for diagnosing OC [ 23 , 24 ]. A tiny tissue biopsy may be taken from the mouth cavity if an examination reveals an abnormal area so that a pathologist can examine it under a microscope for cancer cells.…”
Section: Oral Cancer and Salivary Markersmentioning
Early detection is crucial for the treatment and prognosis of oral cancer, a potentially lethal condition. Tumor markers are abnormal biological byproducts produced by malignant cells that may be found and analyzed in a variety of bodily fluids, including saliva. Early detection and appropriate treatment can increase cure rates to 80–90% and considerably improve quality of life by reducing the need for costly, incapacitating medicines. Salivary diagnostics has drawn the interest of many researchers and has been proven to be an effective tool for both medication monitoring and the diagnosis of several systemic diseases. Since researchers are now searching for biomarkers in saliva, an accessible bodily fluid, for noninvasive diagnosis of oral cancer, measuring tumor markers in saliva is an interesting alternative to blood testing for early identification, post-treatment monitoring, and monitoring high-risk lesions. New molecular markers for oral cancer detection, treatment, and prognosis have been found as a result of developments in the fields of molecular biology and salivary proteomics. The numerous salivary tumor biomarkers and how they relate to oral cancer and pre-cancer are covered in this article. We are optimistic that salivary protein biomarkers may one day be discovered for the clinical detection of oral cancer because of the rapid advancement of proteomic technology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.